BioSpace News Archive

Do you need to be passionate about work to be happy and successful? Well, if you want to be then here are some facts that you must know to be productive.

Abionic AB announced the successful closing of a CHF20 million Series C financing.

Ipsen announced that the European Medicines Agency (EMA), the European regulatory authority, has validated the filing of a new application for an additional indication for Cabometyx®, for patients with previously treated advanced Hepatocellular Carcinoma (HCC).

Exelixis, Inc. announced that its partner Ipsen received validation of the application for variation to the CABOMETYX® (cabozantinib) marketing authorization from the European Medicines Agency (EMA) for the addition of a new indication for patients with previously treated advanced hepatocellular carcinoma (HCC).

Evotec AG reported financial results and corporate updates for the fiscal year ended 31 December 2017.

Results from a study of women with metastatic breast cancer demonstrate that DiviTum can provide faster evaluation of treatment efficacy than today’s standard methods and give precise prognosis.

Owlstone Medical announced the launch of its Breath Biopsy® Kits, based on the company’s proprietary Breath Biopsy platform.

Boston Scientific Corporation announced the U.K. Court of Appeal dismissed Edwards Lifesciences’ appeal and upheld a prior court decision that Edwards’ Sapien 3™ device infringes Boston Scientific patent EP (UK) 2 926 766 and that all claims of that patent are valid.

GB Sciences, Inc. is extremely pleased to announce it has signed a letter of intent to purchase 100% of the ownership interests of NevadaPURE’s Las Vegas operation for $28 million in cash and the assumption of approximately $5 million of outstanding liabilities.

Medivir AB announces that the prospectus, which has been prepared as a result of the conversion of all class A shares in Medivir to class B shares, is now available on Medivir’s website, www.medivir.se.